BioLargo, Inc. · OTC:BLGO

BioLargo — Investor Presentation (July 2019)

56 slides from BioLargo's investor presentation, Jul 31, 2019

  1. Slide 1: We Make Life Better

    We Make Life Better r(' BioLargo Innovator &S Sustainable Solutions Provider Stock Symbol: BLGO Westminster, CA ‘Safe Harbor Statement The statements contained herein, which ae not hstonca, are fowardiooking statements that are subject fonsks and uncertainties that could cause actual results to dife

  2. Slide 2: Innovative solutions — patented products, technologies, and talent

    Innovative solutions — Patented products, technologies, and talent 20 Patents 5 Pending Diverse markets Veteran engineering services team California general, electrical and plumbing contractors Commercial Po | CupriDyne’ (Cnciean A reduc of OdorN More, \O} BioLargo Tegner Semen Renato ‘a podit of Bo

  3. Slide 3: Recent Highlights

    Recent Highlights Odor division heading toward profitability + 4 major national accounts signed, (finally) gearing up + Cannabis industry distribution agreement Engineering division outside revenues exceeded expenses in Q4 and new major customers expanding revenue base + USAF subcontracts + EPASBIR

  4. Slide 4: BioLargo addressable markets

    “eligho addressable markets Clean Air Solutions - $1.8B Landfills: $230M Transfer stations: $350M WT Plants: $720M Cannabis production and processing Wound Care Solutions $2.34B Dental: $264M Wound care: $75M Orthopedic: $28 Engineering Services. >$100M Early regional market: $1.5M Internal + extern

  5. Slide 5: Experienced management with diverse talents

    Dennis Calvert, President and CEO} Experienced management with diverse talents executive experience Cha President 4 f Randall Moore, BLEST President f € Industry experts fame Fo ‘De oe Richard Smith, Exceptionally qualified PhDs f Pro, Bolan and engineers on staff Dargan, CFO

  6. Slide 6: BioLargo's solutions vetted through collaboration

    BioLargo’s solutions vetted through collaboration a (ieee (B) UNIVERSITY OF HEA AVBERTA atte “C2 oo... UGE] Oeenss ©") tt Nan bed National Water Research Institute Ca CHAE ACEPU | SR Q Environmental Research & Education Foundation x eae EREF iE GP iA fortes, 7) SUSTAIN sits EPC®R Ag fesingosy (( %)

  7. Slide 7: Goals for Coming Year

    Goals for Coming Year Odor-No-More v continued 2-3X per month top-line growth v__ expand sales and marketing department v accelerate growth in cannabis industry BLEST Engineering v__ expand external client base v provide internal development and engineering support v implement full services solution

  8. Slide 8: Odor-No-More July 2019 Update

    Odor-No-More” July 2019 Update

  9. Slide 9: CupriDyne Clean Industrial Odor and VOC Eliminator

    Gusting CLEAN CupriDyne® Clean Industrial Odor and VOC Eliminator Eliminates odors — no masking Non-pesticide, non-toxic Saves customers 25-50% Top 4 waste handlers adopting under national contract opr Department of Pesticide Regulation

  10. Slide 10: Design, Build and Install Expertise

    Design, Build and Install Expertise “st a A

  11. Slide 11: Design, Build and Install Expertise

    Design, Build and Install Expertise \ 3 Hes ara

  12. Slide 12: Design, Build and Install Expertise

    Design, Build and Install Expetlise A ee 4 STG I, Wen, 4 eee, te.

  13. Slide 13: Design, Build and Install Expertise

    Design, Build and Install Expertise

  14. Slide 14: Design, Build and Install Expertise

    Design, Build and Install Expertise

  15. Slide 15: Design, Build and Install Expertise

    Design, Build and Install Expertise

  16. Slide 16: CupriDyne Clean in action

    CupriDyne Clean in action

  17. Slide 17: CupriDyne Clean in action

    CupriDyne Clean in action

  18. Slide 18: CupriDyne Clean in the $1B+ U.S. Market

    CupriDyne Clean in the $1B+ U.S. Market U.S. Transfer Stations TAM: U.S. Wastewater Treatment TAM: Landfills TAM: $228 Composting: TAM $364 million/year $720 million/year million/year $118 million/year

  19. Slide 19: Just Getting Started in this Huge Market Opportunity

    Just Getting Started in this Huge Market Opportunity Celt 1% market 3% market 10% market TAM (Total sites(US revenue share share share Addressable Market") per site Market - US) per year Landfills 1,900 $120,000 $2.3M $6.8M $23M $230M Transfer 7,600 $48,000 $3.7M $10.9M $37M $350M Stations Wastewate

  20. Slide 20: CupriDyne in the Cannabis Industry

    Misting rings ‘4 CupriDyne in the Cannabis Industry “Pick and Shovel” play 15,000+ licensed operations in California alone New market opportunities through partnerships with established players

  21. Slide 21: CupriDyne Clean Demonstrated Effective Against Terpenes

    CupriDyne Clean Demonstrated Effective Against Terpenes E fost reatrent R Preveament peak ‘Provestnent peak j Posttreatment ~ n0 peak St ee ae Nea, N itl Figure 1 - Limonene pre and post treatment Figure 2 - Myrcene Pre and Post Treatment chromatogram Chromatogram

  22. Slide 22: What's Happening at BLEST - July 2019 Update

    (© BioLargo Engineering , Science & Technologies What's Happening at BLEST July 2019 Update

  23. Slide 23: BioLargo Engineering

    BioLargo Engineering v Trusted industry veterans v Innovators ¥ Solutions Providers (Op BioLargo Engineering , Science & Technologies

  24. Slide 24: Cleaner Water

    Cleaner Water * EPA SBIR Phase | Grant: $100,000 * BLEST’s Aqueous Electrostatic Concentrator (AES). PFAS concentrating apparatus. * Initial results indicate potential to remove >90% PFAS. Continuous flow prototype in development * Applying for Phase II funding in September. Up to $1,000,000: scale-

  25. Slide 25: Significant Wins and Anticipated Contracts

    Significant Wins and Anticipated Contracts + Feasibility and placement study for 1.1M tons of magnesium rich = production tailings in Moss Landing, California - $65K to date, with = b h ate potential to grow into 7 figures. nee + Teaming with Bhate and Haztrain. Won contracts for F2F environmental c

  26. Slide 26: Cannabis Opportunity

    Cannabis Opportunity * CupriDyne Clean based scrubbers for terpenes in the Cannabis industry * CC reacts with and destroys terpenes. * Terpenes cause ozone and haze, nuisance smells. * Current technologies inadequate. + Anew pilot scrubber system involving CC is under design/construction and testing

  27. Slide 27: Stormwater Opportunity

    Stormwater Opportunity + Stormwater-specific AOS designs + Third-party evidence has shown that CupriDyne technology is valuable for pre- treatment of storm water in water reclaim operations. + Dosing equipment using the AOS technology | that can convert a fraction of the CupriDyne into highly oxidat

  28. Slide 28: Take Aways

    Take Aways * These highlights are just a sampling of BLEST activity and don’t touch on organic growth of commercial clients. + Potential Return on Shareholder Investment can be significant, and it is our goal to make that happen! + We appreciate your trust in our capabilities and faith in our stewar

  29. Slide 29: Contact Information

    Contact Information ¢ Randall Moore, President and CEO Phone: (865)604-3945 + Email: Randall.Moore@Biolargo.com LS O} BioLargo + Email: Kevin.Jackson@Biolargo.com Enoingeting Science & Techaoiogiss BLEST Office Address: 105A Fordham Road Oak Ridge, TN 37830

  30. Slide 30: Clyra Medical Technologies - July 2019 Update

    CLYRA Medical Technologies Inc +) . July 2019 Update Oya

  31. Slide 31: Clyra Medical Technologies

    Clyra Medical Technologies Gold standard advanced wound care Gentle & Effective No known acquired bacterial resistance FDA 510(k) application in process Dressings Liquid wound cleansers Woven and non. woven Orthopedics

  32. Slide 32: Game Changing Solutions to Key Medical Problems

    Clyra Medical @cLYRA Technologies. Game Changing Solutions to Key Medical Problems Two product platforms — both available in multiple formats, enhanced by proprietary and unique delivery systems. ¢ Infection Prevention &

  33. Slide 33: Clyra - Infection Prevention & Antimicrobial Control

    Clyra™ * Infection Prevention & Antimicrobial Control “A game-changing Benefits of the Clyra Antimicrobial Technology antimicrobial id, | Extremely High Antimicrobial Efficacy Bio-compatible / Safe / No Known Toxicities Effective Against Biofilm + The result of novel, patent- pending cuprous/iodine-

  34. Slide 34: Clyra's SkinDisc

    Clyra’s SkinDisc™ Patented, revolutionary stem cell wound therapy Acquired in 2018 250+ patient case studies performed. 100% limb salvage with no adverse reaction

  35. Slide 35: SkinDisc Case Study — Diabetic Foot Ulcer

    SkinDisc™ Case Study 1 — Diabetic Foot Ulcer v Innovative and powerful v Successfully treats wounds where competing products fail v Saves limbs, saves lives

  36. Slide 36: SkinDisc Case Study 2 — Chronic Leg Wound

    INDISC ase study Z— Chronic Leg Wound 87 year-old patient with chronic leg Highlighted area is where wound SkinDisc™ was, applied Before VA SkinDisc After SkinDisc¢

  37. Slide 37: Pursuing Licensing Opportunities

    Pursuing Licensing Opportunities * Targeting complementary technology acquisition + Round out Clyra’s product portfolio + Will keep you posted!

  38. Slide 38: Global Market

    Global Market Global non-US markets are more than 2x the size of US markets, and growing rapidly + Number of annual non-US total joint operations is more than double those done in the US + Global non-US incidence of diabetes is more than double the US figures and is accelerating Across virtually all

  39. Slide 39: BioLargo Water - July Update 2019

    6) BioLargo Water July Update 2019 “dl Les Edmonton, AB, Canada LAOS:

  40. Slide 40: Our Mission

    Our Mission To provide the world with an affordable, eco- friendly solution to point-of-use water treatment for diverse applications How? By commercializing a water treatment solution — the Advanced Oxidation System — that empowers industry to conserve water, electricity, and money, while treating f

  41. Slide 41: The Solution: AOS

    The Solution: AOS * Low CAPEX, low OPExX, lowest energy use in the industry * Eliminates bacteria, viruses, and 2 AOS protozoa with highest fidelity Asxenede Cie Men byeie + Even hits hard-to-treat _———~____. micropollutant pharmaceuticals + Paradigm shift in industrial wastewater treatment

  42. Slide 42: Target Markets

    Target Markets TAM 44B SAM 10.75B Total Addressable Market (TAM): $448 Serviceable Addressable Market (SAM) — Poultry processing, food & beverage, and stormwater: $10.75B 5-year post-launch projected revenues in gateway market: $4oM 5-year post-launch projected revenues within Estimated Anticipated

  43. Slide 43: Poultry Processing: Water Intensive

    Poultry Processing: Water Intensive (08 Million Chickens 26 Liters / Bird Le 2.8 Billion Liters of } — ” Fresh Water/ Year $11.6M/ Year’ in water costs in Alberta Poultry industry alone based on a total water charge of $4.1334/m® including water rate, discharge rate, and surcharges (EPCOR and Edmont

  44. Slide 44: The solution — AOS

    The solution — AOS és Reuse + Met USDA water Poultry wor reconditioning guidelines Wastewater ~~~ = . + Bacterial contamination ayer + High BOD, TSS and Discharge TKN + No overstrength surcharges MWD ICP-funded poultry industry validation study available here: http://bewaterwise.com/assets/2015icp-b

  45. Slide 45: AOS Scalability AOS reactor designs

    AOS Scalability 2 AOS reactor designs Modular, scalable technology Small physical footprint crucial for certain applications Spiral design — increased scalability + 5gallons/min per 8” reactor unit * 20 units = 144,000 gallons/day

  46. Slide 46: AOS Clean Water Technology

    AOS Clean Water Technology A LEAP FORWARD IN WATER TREATMENT Low cost + Flexible and modular Lowest power + Extreme performance consumption

  47. Slide 47: AOS Treatment Train Recently Installed at Sunworks Farm

    AOS Treatment Train Recently Installed at Sunworks Farm Pilot treatment train installed on- site at Sunworks Farm Full treatment train (pre- treatment, filtration) Water quality analysis capabilities on-site GCE Oxidation System

  48. Slide 48: Slide 48

  49. Slide 49: Slide 49

  50. Slide 50: Slide 50

  51. Slide 51: Post Filtration

    Post Filtration Skid Post Coarse Filtration

  52. Slide 52: Slide 52

  53. Slide 53: AOS = cost-effective solution for micropollutants

    HO on oy 1Th-estradiol cor Benzofalpyrene AOS = cost-effective solution for micropollutants Right now, industry has no feasible, affordable solution AOS negates toxic effects of certain micropollutant pharmaceuticals AOS is a breakthrough for municipalities Discussed in detail at our blog: hips /ibj

  54. Slide 54: Competition

    Competition TotalOPEX Total CAPEX Removes Removes bacteria, Sensitivity to (CDN$/m*) (CDN $) organics viruses & protozoa turbidity and Tss Advanced 0.17" 83,070" + + + Oxidation System (AOS) Ultraviolet (UV) 0.22 172,472 5 - ++ Ozone 0.54 290,447 t - ++ Disinfection performance metrics for bacterial

  55. Slide 55: Market Traction

    Market Traction + 4 pilots* Poultry processing Food & Beverage Stormwater Municipal Waste Water *- Demonstrates commercial pull and economics of the AOS *More information available upon request

  56. Slide 56: Contact

    Contact: Richard Smith President & CEO. BioLargo Water, Inc. 14921, 188 st Edmonton, AB 780-233-6523 richard@biolargo.com . ’ BioLargo The BioLargo b We Make life Better Family of Companies BioLargo, Inc. is a sustainable science, technology & full-service environmental engineering company that make

BioLargo — Investor Presentation (July 2019) on 6ix